HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
about
Statins for the prevention of dementiaStatins for the treatment of dementiaStatins for the treatment of dementiaStatins for the treatment of Alzheimer's disease and dementiaStatins for the prevention of dementiaPleiotropic effects of statinsStatins as regulators of redox state in the vascular endothelium: beyond lipid loweringEndothelium-dependent relaxations in the aorta from K(2p)6.1 knockout miceEffects of simvastatin on cardiac performance and expression of sarcoplasmic reticular calcium regulatory proteins in rat heartAtorvastatin at reperfusion reduces myocardial infarct size in mice by activating eNOS in bone marrow-derived cells.Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat dietPretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channelAmeliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats.HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthaseFarnesyltransferase inhibitor improved survival following endotoxin challenge in mice.Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein.Simvastatin re-couples dysfunctional endothelial nitric oxide synthase in experimental subarachnoid hemorrhageTherapeutic interventions and oxidative stress in diabetesMechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus.Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study.Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells.IL-1β and IL-18: inflammatory markers or mediators of hypertension?The effects of anti-obesity intervention with orlistat and sibutramine on microvascular endothelial function.Hypertension and lipids: lipid factors in the hypertension syndrome.Lipid lowering: another method of reducing blood pressure?Microcirculation as a target for the anti-inflammatory properties of statins.High doses of simvastatin upregulate dopamine D1 and D2 receptor expression in the rat prefrontal cortex: possible involvement of endothelial nitric oxide synthase.Endothelial relaxation mechanisms and oxidative stress are restored by atorvastatin therapy in ovariectomized rats.Beyond lipid-lowering: effects of statins on endothelial nitric oxide.Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia.Vascular NAD(P)H oxidases: specific features, expression, and regulation.Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch.Statin treatment in hypercholesterolemic men does not attenuate angiotensin II-induced venoconstriction.Rosuvastatin attenuated contrast-induced nephropathy in diabetes patients with renal dysfunction.Agents that stabilise atherosclerotic plaque.Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypassThe cardioprotective effects of statins.Cholesterol level and statin use in Alzheimer disease: II. Review of human trials and recommendations.Imaging of Intracellular and Extracellular ROS Levels in Atherosclerotic Mouse Aortas Ex Vivo: Effects of Lipid Lowering by Diet or AtorvastatinStatins Reduces the Risk of Dementia in Patients with Late-Onset Depression: A Retrospective Cohort Study.
P2860
Q24186591-38778FCA-742F-4350-A146-B64EC6A477D5Q24194901-3E0BBDC2-17A6-4DF7-A04E-444B48FCC613Q24236484-49669200-696F-42C1-9783-237D0AC1924CQ24240305-906803ED-F958-4C8A-88FB-957CEBF354FEQ24241335-6C513FB6-1DDF-49AD-B7F7-304E13830C28Q24647863-B9910028-B6C3-439A-A002-F7959BA24E0DQ26853120-1C3578D6-5A41-43DA-B5A1-E997173479BEQ28510643-B33DB346-2534-4E00-85B6-72375125AAD1Q28580295-DEF22A92-8323-4ACA-BB84-F06DEECC5174Q30301174-0CCD8915-FD93-43F2-99A9-8DFA5E33B551Q30482887-EA84EFAB-6EE0-4B72-8709-E959D32A5E2FQ30498652-2CEB1DD6-3109-45CE-8698-C5906C9772ADQ33358995-6967D525-29E0-497C-A418-CDE5635A8BD9Q33565388-48D2B8DC-1051-4A77-B991-C778B17D9188Q33620009-7D47A549-14A8-43DE-A197-421AC8A4CED7Q33702090-F21C3781-8C38-43E8-9434-D0628E250D53Q33836890-C47E128C-1A19-4928-AA00-1CC4C5705354Q33870395-54957EE4-F044-46F5-9200-171A6FD743F0Q33929661-0D7A0DBD-8648-4A35-9913-311231B1F962Q34156106-CE0990E1-CE63-42EA-B6A0-AEBE2D9630DCQ34737702-05304F29-7944-4B93-97EE-B7165EAD8259Q34914125-65BF0823-2512-447D-AD3A-CA35721DD455Q34977759-25B1593B-5B98-4670-8F66-57682114D492Q34990490-639137AB-2944-4F23-A881-6674BCE23BA1Q35005589-E3A4C481-3E24-47AE-8581-5B186CF5EF7EQ35026501-EA1967CD-BCFE-4CBB-A4C1-FD7C12E4105FQ35048736-4259BD38-31E8-4808-8929-F7E385ADDCABQ35053761-E91CA26B-6E82-4DD0-BF1A-C2584C8CF097Q35084723-8756DB15-86E2-4F56-8D3D-8155F4A28440Q35118290-6D8AD650-869D-487A-B847-A0A9F7351E23Q35175526-93D292FD-49AF-4F4F-B806-13AE5D910661Q35212986-E9EC8081-148C-4EB4-90FC-F8A503877581Q35284008-329B64E8-FC0C-480C-852C-91DDCB736EABQ35480312-B3CCF845-0B08-4FDB-BB7A-B5E182A7838DQ35547296-3BD47F05-94BA-4DFA-969B-CFE6228E3737Q35581141-970D047F-6518-415F-A0A1-91CB1D8E7440Q35602770-E3AD5423-E213-4F2D-B2A5-EB13CD7B25F4Q35642416-926C7782-B891-471A-A969-568DACACDBF2Q35670332-3AC0D739-BC05-408F-9B9D-DA59FEFD5D67Q35780206-EA2938E7-B598-42BB-9E45-E7DF16AE75C7
P2860
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
HMG-CoA reductase inhibitors i ...... on of reactive oxygen species.
@en
HMG-CoA reductase inhibitors i ...... on of reactive oxygen species.
@nl
type
label
HMG-CoA reductase inhibitors i ...... on of reactive oxygen species.
@en
HMG-CoA reductase inhibitors i ...... on of reactive oxygen species.
@nl
prefLabel
HMG-CoA reductase inhibitors i ...... on of reactive oxygen species.
@en
HMG-CoA reductase inhibitors i ...... on of reactive oxygen species.
@nl
P2093
P356
P1433
P1476
HMG-CoA reductase inhibitors i ...... on of reactive oxygen species.
@en
P2093
A T Bäumer
G Nickenig
S Wassmann
P304
P356
10.1161/01.HYP.37.6.1450
P407
P577
2001-06-01T00:00:00Z